Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Toxicity to reproduction

Currently viewing:

Administrative data

Endpoint:
three-generation reproductive toxicity
Type of information:
experimental study
Adequacy of study:
key study
Study period:
No data.
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment
Remarks:
Study not performed to GLP or guideline. But has been reviewed by an expert assessor (see expert report attached) and determined to be suitable for use for the purposes of REACH registration. See overall remarks for further discussion on deficiencies. 1. Only one dose level was included in the study. 2. Test material was not analyzed in diet. No impurity profile of test material was provided. 3. The group size was smaller than the 20 females and 10 males required in OECD guideline 416. 4. Only one dose level was tested with a control group. 5. There was no recorded acclimation period for the P generation. 6. Daily observations of parents and observations of abnormal behaviour of offspring are not reported. 7. Body weights: Parental body weights were not recorded during gestation and lactation. 8. Food consumption was not determined. 9. Estrous cycle was not evaluated. 10. Sperm parameters were not included. 11. Offspring sex and sex ratios were not determined. Litter body weight was reported; however, individual pup body weights were not recorded. 12. There is no report of gross pathology and necropsy observations. 13. Organ weight data for the uterus, epididymides (total and caudal), prostate, seminal vesicles with coagulating gland, pituitary gland, adrenals and thyroid gland were not included. 14. Histopathology was conducted only on the F3b offspring and did not include the following organs: uterus, cervix, vagina, epididymides, seminal vesicles, prostate, coagulating gland, pituitary gland. Note that the known target organ (kidney) was evaluated. 15. Statistics are not reported.
Justification for type of information:
REPORTING FORMAT FOR THE ANALOGUE APPROACH
See read-across justification report under Section 13 ‘Assessment Reports’.

1. HYPOTHESIS FOR THE ANALOGUE APPROACH
In accordance with REACH Annex XI, Section 1.5, of Regulation (EC) No. 1907/2006 (REACH) the standard testing regime may be adapted in cases where a grouping or read-across approach has been applied.

The similarities may be based on:
(1) a common functional group
(2) the common precursors and/or the likelihood of common breakdown products via physical or biological processes, which result in structurally similar chemicals; or
(3) a constant pattern in the changing of the potency of the properties across the category

1. Both substances are inorganic salts of a monovalent cation from Group 1A of the periodic table, and triphosphoric acid. Thus, they share the Na+ or K+ cation and P3O105- anion.
2. Both the Na+ and the K+ cation have a similar biological function and therefore triphosphate salts of these types are not considered to differ in their systemic toxicity profile; differences arise in their local effects profile due to the increasing or decreasing acidity/alkalinity and buffering capacities of the substances. This has been shown not to have an effect on systemic toxicity.
3. In addition, both salts have been shown to be of similar low toxicity in acute oral studies and therefore comparisons can be drawn to allow read-across. Therefore it is not considered to be scientifically justified to perform any further in vivo studies.

2. SOURCE AND TARGET CHEMICAL(S) (INCLUDING INFORMATION ON PURITY AND IMPURITIES)
See read-across justification report under Section 13 ‘Assessment Reports’.

3. ANALOGUE APPROACH JUSTIFICATION
See read-across justification report under Section 13 ‘Assessment Reports’.

4. DATA MATRIX
See read-across justification report under Section 13 ‘Assessment Reports’.
Cross-reference
Reason / purpose for cross-reference:
read-across: supporting information

Data source

Referenceopen allclose all

Reference Type:
publication
Title:
Summaries of toxicological data
Author:
Hodge HC
Year:
1964
Bibliographic source:
Fd Cosmet, Toxicol (2)147-154
Reference Type:
study report
Title:
Unnamed
Year:
1959

Materials and methods

Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
A reproduction study spanning three generations of rats reared and maintained on diets containing 0.0% and 0.5% pentasodium triphosphate (STPP). Per generation two different litters were bred; one was sacrificed and the other was bred to produce the next generation. Matings were carried out between 16 females and 8 males in each group when the rats were 100 days old. Observations were limited to: the number of pups born, pup mortality up to 21 days, organ weights and histopathological changes in the tissues and organs.
GLP compliance:
no
Remarks:
Study predates GLP
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Pentasodium triphosphate
EC Number:
231-838-7
EC Name:
Pentasodium triphosphate
Cas Number:
7758-29-4
Molecular formula:
Na5P3O10 H5-xP3O10Nax (where x is approximately 5) 6H2O.Na5P3O10
IUPAC Name:
Pentasodium triphosphate
Details on test material:
- Name of test material (as cited in study report): Sodium tripolyphosphate
- Substance type: Anhydrous granular
- Physical state: solid
- Analytical purity: no data
- Lot/batch No.: Lots 3561210 Lot D, Lot #195001-8 and Lot #5071018
- Stability under test conditions: Stable under at room temperature.

Test animals

Species:
rat
Strain:
other: Rochester Strain (Ex-Wistar 1923)
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Age at study initiation:
The parental generation were mated when they were 100 days old. Succeeding generations were also mated at 100 days of age.
- Weight at study initiation: 60g
- Housing: Galvanized iron cages with screen wire doors. The bottoms of the cages were pans filled with wood
shavings.
- Diet: e.g. ad libitum
- Water :e.g. ad libitum


ENVIRONMENTAL CONDITIONS
- no data

Administration / exposure

Route of administration:
oral: feed
Vehicle:
unchanged (no vehicle)
Details on exposure:
DIET PREPARATION
Diets were prepared at weekly intervals by mixing, using a mechanical mixer, the appropriate amounts of STPP as needed into the control ration. Diet mixtures were stored in galvanized iron buckets with covers.
Details on mating procedure:
- M/F ratio per cage: 1 male:2 female
- Length of cohabitation: 7 days.
- Proof of pregnancy: no data.
- Unsuccessful pairing replacement of first male by another male with proven fertility - no.
- Further matings after two unsuccessful attempts: no data.
- After successful mating each pregnant female was caged (how): no data.
- other: As there were two matings per generation the males were rotated so that at each mating a different male would be placed in the cage with the females.

Sixteen females and 8 males will be mated at 100 days of age from each of the above 2 groups (controls and 0.5% tripolyphosphate). They will be mated again 10 days after weaning of the first litter. Sixteen females and 8 males from the second litters will be selected from each group at weaning and continued on their respective diets. When 100 days old they will be mated; then mated again 10 days after weaning the first litter. This procedure will be
repeated with the rats to produce a second litter of the third generation.
Analytical verification of doses or concentrations:
not specified
Details on analytical verification of doses or concentrations:
Not applicable.
Duration of treatment / exposure:
Exposure took place:
- for 100 days prior to mating
- 21 days of gestation
- during lactation (the P1, F1b and F2b)
- the F3b were exposed for their first 21 days after which time they were sacrificed.
- Following weaning of the F1b litter, 8 males and 16 females for the control group and the treated group were fed their respective diets for 100 days. 
Litters were culled to 10 pups with approximately 5/sex/group on postnatal day 5.

Frequency of treatment:
Daily in diet (ad libitum).
Details on study schedule:
See table 1 for details on the study schedule.
Doses / concentrations
Remarks:
Doses / Concentrations:
0.5% in diet
Basis:
nominal in diet
No. of animals per sex per dose:
P1, F1, F2, F3: 16 females and 8 males
Control animals:
yes, concurrent no treatment
Details on study design:
- Dose selection rationale: 0.05% and 0.5% diets were considered. After 100 days the 0.5% group exhibited no depression of bodyweight and was selected for use in the reproduction study.
- Other: The first litters born, the F1a,2a,3a were sacrificed. The second litters, F1b,2b were mated to produce the next generation.
Positive control:
There was no positive control.

Examinations

Parental animals: Observations and examinations:
CAGE SIDE OBSERVATIONS: No data

DETAILED CLINICAL OBSERVATIONS: No data

BODY WEIGHT: Yes
- Time schedule for examinations: Body weights were measured weekly during the 100 day pre-mating exposure for each generation.

FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study): No

WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): No
Oestrous cyclicity (parental animals):
Not evaluated.
Sperm parameters (parental animals):
Not evaluated.
Litter observations:
STANDARDISATION OF LITTERS
- Performed on day 5 postpartum: [yes]
- excess pups were sacrificed to leave 10 per litter.

PARAMETERS EXAMINED
The following parameters were examined in [F1 / F2 / F3] offspring:
number of pups, pups/litter, pup mortality up to 21 days of age, weight gain per litter.

GROSS EXAMINATION OF DEAD PUPS: No
NOT EVALUATED: sex of pups, presence of gross anomalies, physical or behavioural abnormalities, no individual pup body weights
Postmortem examinations (parental animals):
SACRIFICE
- The F1a,2a,3a were sacrificed at 30 days postpartum.
- No data on parental fate after the mating and weaning.

GROSS NECROPSY
- no data.

HISTOPATHOLOGY / ORGAN WEIGHTS
Not performed for parental rats.
Postmortem examinations (offspring):
SACRIFICE
- The non-parental litters, F1a , F2a , F3a , and F3b were sacrificed after 30 days.
- Observations amongst these litters were limited to litter weights on the 21st day.
- In the F3b histopathological and organ weight examinations were performed.

GROSS NECROPSY
F3b examined only.

HISTOPATHOLOGY / ORGAN WEIGTHS - The ten males and ten females from final litter, the F3b litter, were evaluated for body weight, histopathology.
- Histopatholigcal examinations performed for: Liver, kidneys, gonads, lungs, brain, stomach, heart, spleen, adrenal, stomach, large and small intestines, bladder, lymph nodes, gut, marrow, pancreas)
- Organ weights recorded for: Liver, kidneys, testes, lungs, brain, stomach, heart, spleen.
- Organ weights not recorded for: Uterus, ovaries, epididymides (total and cauda), prostate, seminal vesicles, pituitary, thyroid, adrenal glands.
- Histopathological examinations not performed for: Vagina, uterus with cervix, epididymis, seminal vesicle, prostate coagulating gland.

Results and discussion

Results: P0 (first parental generation)

General toxicity (P0)

Clinical signs:
not specified
Body weight and weight changes:
no effects observed
Food consumption and compound intake (if feeding study):
no effects observed
Ophthalmological findings:
not examined
Haematological findings:
not examined
Clinical biochemistry findings:
not examined
Urinalysis findings:
not examined
Organ weight findings including organ / body weight ratios:
no effects observed
Histopathological findings: non-neoplastic:
not examined
Other effects:
not examined

Reproductive function / performance (P0)

Reproductive function: oestrous cycle:
not examined
Reproductive function: sperm measures:
not examined
Reproductive performance:
no effects observed
Description (incidence and severity):
based on equivalent numbers of pups born and surviving weaning in the controls and treated groups.

Details on results (P0)

See table 2 (attached document - "reproductive performance") for a comparison of the control and treated groups's reproductive performance.

Effect levels (P0)

open allclose all
Key result
Dose descriptor:
NOAEL
Effect level:
250 mg/kg bw/day
Based on:
test mat.
Remarks:
test material in diet.
Sex:
male/female
Basis for effect level:
other: No effects observed
Key result
Dose descriptor:
NOAEL
Effect level:
0.5 other: % in diet
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: no effects noted

Target system / organ toxicity (P0)

Key result
Critical effects observed:
no

Results: F1 generation

General toxicity (F1)

Clinical signs:
not examined
Mortality / viability:
no mortality observed
Description (incidence and severity):
See table 2 (attached)
Body weight and weight changes:
no effects observed
Description (incidence and severity):
See Table 2 (attached)
Sexual maturation:
no effects observed
Organ weight findings including organ / body weight ratios:
no effects observed
Gross pathological findings:
no effects observed
Histopathological findings:
no effects observed

Details on results (F1)

- See Table 2 (attached.) for details on viability and bodyweights.
The attached graphs highlight the similiarity in growth rates between control and treated groups for the F1b and F2b.

- For Organ weights see Table 3 (attached). Treated and control groups were considered to be comparable for all organs weighed.
Inspection shows nearly identical average weights, both fresh weights and on basis of body weights. For both the male and the female rats, the average kidney weights (basis body weight) are slightly greater for the rats maintained on the 0.5% TPP diets than on the control diets. These differences, however, are not statistically significant.

- There were no treatment-related histopathological findings.

Effect levels (F1)

open allclose all
Key result
Dose descriptor:
NOAEL
Generation:
F1
Effect level:
250 mg/kg bw/day
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: no effects observed
Key result
Dose descriptor:
NOAEL
Generation:
F1
Effect level:
0.5 other: % in diet
Based on:
test mat.
Sex:
male/female
Remarks on result:
other: no effects noted

Target system / organ toxicity (F1)

Key result
Critical effects observed:
no

Results: F2 generation

General toxicity (F2)

Clinical signs:
not examined
Body weight and weight changes:
no effects observed

Effect levels (F2)

open allclose all
Key result
Dose descriptor:
NOAEL
Generation:
F2
Effect level:
250 mg/kg bw/day (nominal)
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: no effects noted
Key result
Dose descriptor:
NOAEL
Generation:
F2
Effect level:
0.5 other: % in diet
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: no effects noted

Target system / organ toxicity (F2)

Key result
Critical effects observed:
no

Overall reproductive toxicity

Key result
Reproductive effects observed:
no

Any other information on results incl. tables

This study included only one dose level of the test material, 0.5% in the diet. There were occasional fluctuations in the fertility index.  The lower fertility index in the F2a, F3a and F3b litters is considered spurious and not treatment-related.  The fertility indices of the treated group were greater than the control group for some litters (F1a, F2b); the same as the control group for the F1b litter, and less than the control group for other litters (F2a, F3a, F3b).  These variations are not considered to show a treatment-related effect on fertility.  The duration of pregnancy, live birth index, litter size, litter weights, survival index, viability index and lactation index were all comparable between control and treated groups.  Organ weights were similar between control and treated groups.  There were no treatment-related histopathological findings.

Parameter

Control

High dose

Generation

M

F

M

F

Mortality

Incidence

P

0

0

0

0

F1

0

0

0

0

F2

0

0

0

0

F3

0

0

0

0

Food consumption

% of control

NA

NA

NA

NA

Body weight gain

% of control

100

100

100

100

Clinical Observations

specify effects

Incidence

NA

NA

NA

NA

Organ weights (F3b)

% of control

95 -103

95 -103

95 -103

95 -103

Pathology

Histopathologic examination: F3b

Immature testes

Renal cyst

Parasites in intestine

Focal pulmonary hemorrhage

Parasites in renal pelvis

Incidence

10

-

-

-

-

-

-

1

1

-

10

1

1

1

-

-

-

-

-

2

Reproductive Performance

Mating index: P

-

NA

NA

F1

-

NA

-

NA

F2

-

NA

-

NA

F3

-

NA

-

NA

Fertility index: P, la

-

87.5

-

93.8

F1b

-

75

-

75

F2a

-

82.3

-

68.8

F2b

-

76.5

-

81.3

F3a

81.3

-

68.8

F3b

80

-

62.5

Number of implantation sites

Mean

-

NA

-

NA

Duration of pregnancy: P, 1a

Mean days

24.7

24.06

F1b

25.1

-

25.25

F2a

23.36

-

24.91

F2b

25

-

24.4

F3a

25.8

-

25.1

F3b

25.2

-

25

Birth index

Live birth index: P, 1a

-

93.8

-

100

F1b

93.8

-

100

F2a

100

-

100

F2b

100

-

93.8

F3a

93.8

-

100

F3b

100

87.5

Gestation index

Litter size: P, 1a

Mean

-

8.9

-

9.2

F1b

11

-

13

F2a

9.2

-

9.5

F2b

10.7

-

10.2

F3a

10.4

-

10.2

F3b

8.4

-

10.5

Litter weight: P, 1a

Mean, day 21, g

-

307

-

283

F1b

348

-

392

F2a

279

-

341

F2b

379

-

325

F3a

270

349

F3b

319

-

388

Pup weight, 1a

Mean: day 21, g

36.8

-

37.8

F1b

42.2

-

40.5

F2a

42.9

-

42.1

F2b

40.3

-

41.5

F3a

41.4

-

43.7

F3b

45.6

-

41.9

Sex ratio

Male/female

NA

NA

Survival index: P, 1a

Day 5

91.4

-

95.6

F1b

91.6

-

97.4

F2a

93.3

-

88.6

F2b

96.7

-

93.4

F3a

82.4

-

85.2

F3b

74.8

-

98.8

Viability index: P, 1a

Day 21

-

86.2

-

81.1

F1b

75

-

74.3

F2a

74.2

-

84.8

F2b

85

-

77

F3a

72.8

-

72

F3b

76.2

-

88

Lactation index: P, 1a

Day 21

86.2

-

81.1

F1b

75

-

74.3

F2a

74.2

-

84.8

F2b

85

-

77

F3a

72.8

-

72

F3b

76.2

-

88

Sperm characterization

NA

NA

Number

% of control

NA

NA

Deformations

% of control

NA

NA

Applicant's summary and conclusion

Conclusions:
Three generations of rats reared and maintained on diets containing 0.5% STPP showed no adverse effects to the test material - Control and test data were comparable across the range of observations made. Observations were limited to reproductive performance, pup mortality, organ weights and tissue and organ histopathology. Based on this evidence sodium metaphosphate is not considered to be classified as a reproductive toxicant according to Regulation (EC) 1272/2008 (EU CLP).

Although this study is limited and deficient by modern standards, it is still possible to make some valid scientific conclusions from the data. Adequate data are reported to show no effects on fertility or reproductive performance or on offspring growth and development over three generations with two litters per generation. Thus, the study should be considered acceptable for the dose level tested, 0.5% test material in the diet.